Stay updated on Favipiravir Clinical Trial: Influenza Efficacy & Safety
Sign up to get notified when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.

Latest updates to the Favipiravir Clinical Trial: Influenza Efficacy & Safety page
- CheckyesterdayChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check8 days agoChange DetectedA notice appears at the top of the page announcing NIH website updates and a terminology transition from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check15 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check22 days agoChange DetectedThe ClinicalTrials.gov site revision identifier in the footer changed from v3.7.0 to v3.7.1. The page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThere are no reported textual changes in the provided data; the page content remains unchanged per the diff data.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record with a site-access issue. The detailed trial information, including interventions, endpoints, and locations, appears to have been removed.SummaryDifference15%

Stay in the know with updates to Favipiravir Clinical Trial: Influenza Efficacy & Safety
Enter your email address, and we'll notify you when there's something new on the Favipiravir Clinical Trial: Influenza Efficacy & Safety page.